Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1994 Jun;68(6):3499-504.
doi: 10.1128/JVI.68.6.3499-3504.1994.

Subtype cross-reactive, infection-enhancing antibody responses to influenza A viruses

Affiliations

Subtype cross-reactive, infection-enhancing antibody responses to influenza A viruses

M Tamura et al. J Virol. 1994 Jun.

Abstract

Antibody-dependent enhancement of the uptake of influenza A virus by Fc receptor-bearing cells was analyzed by using virus strains of the three human influenza A virus subtypes, A/PR/8/34 (H1N1), A/Japan/305/57 (H2N2), and A/Port Chalmers/1/73 (H3N2). Immune sera obtained from mice following primary infection with an H1N1, H2N2, or H3N2 subtype virus neutralized only virus of the same subtype; however, immune sera augmented the uptake of virus across subtypes. Immune sera from H1N1-infected mice augmented uptake of the homologous (H1N1) and H2N2 viruses. Antisera to the H2N2 virus augmented the uptake of virus of all subtypes (H1N1, H2N2, or H3N2). Antisera to the H3N2 virus augmented the uptake of the homologous (H3N2) and H2N2 viruses. These results show that subtype cross-reactive, nonneutralizing antibodies augment the uptake of influenza A virus strains of different subtypes. Antibodies to neuraminidase may contribute to the enhanced uptake of viruses of a different subtype, because N2-specific monoclonal antibodies augmented the uptake of both A/Japan/305/57 (H2N2) and A/Port Chalmers/1/73 (H3N2) viruses.

PubMed Disclaimer

References

    1. J Immunol. 1985 Jun;134(6):3643-8 - PubMed
    1. Curr Top Microbiol Immunol. 1985;114:177-255 - PubMed
    1. J Virol. 1988 Jan;62(1):20-6 - PubMed
    1. Lancet. 1988 Jun 4;1(8597):1285-6 - PubMed
    1. Science. 1988 Oct 28;242(4878):580-3 - PubMed

MeSH terms